CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 89 filers reported holding CULLINAN ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,281,224 | -30.0% | 1,688,533 | -16.7% | 0.00% | -100.0% |
| Q2 2023 | $21,814,889 | -16.5% | 2,027,406 | -20.6% | 0.00% | 0.0% |
| Q1 2023 | $26,137,527 | -11.9% | 2,554,988 | -9.2% | 0.00% | 0.0% |
| Q4 2022 | $29,676,782 | -16.3% | 2,812,965 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $35,447,000 | +0.7% | 2,765,005 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $35,197,000 | +42.9% | 2,745,519 | +16.7% | 0.00% | 0.0% |
| Q1 2022 | $24,626,000 | -32.6% | 2,352,125 | -0.6% | 0.00% | 0.0% |
| Q4 2021 | $36,520,000 | -29.1% | 2,366,808 | +3.7% | 0.00% | 0.0% |
| Q3 2021 | $51,492,000 | +73.0% | 2,281,451 | +97.4% | 0.00% | 0.0% |
| Q2 2021 | $29,761,000 | -38.0% | 1,155,765 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $47,974,000 | – | 1,151,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |